Comparison of the efficacy and safety of Bortezomib between the twice-weekly and once-weekly regimens for newly diagnosed multiple myeloma
- VernacularTitle:硼替佐米每周两次与每周一次治疗初诊多发性骨髓瘤的疗效和安全性比较
- Author:
Jing SHEN
1
;
Aijun LIAO
;
Wei YANG
;
Zhuogang LIU
Author Information
- From: Chinese Journal of Hematology 2017;38(8):725-727
- CountryChina
- Language:Chinese
